Analysis of the effectiveness of vaccination against COVID-19 based on real-world data in St. Petersburg von Kurylev, A. A., Zhuravkov, A. A., Kolbin, A. S.

Volltext

PDG1 RECOMBINANT HUMAN ERYTHROPOIETIN VERSUS PLACEBO OR NO TREATMENT IN PATIENTS WITH ANEMIA OF CHRONIC KIDNEY DISEASE: META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS von Kurylev, A.

Volltext

Determination of the reference value of the incremental cost-efficacy and cost-utility coefficient in Russia in oncology von A. S. Kolbin, A. A. Kurylev

Volltext

Pharmacoeconomic evaluation of ipragliflozin in combination with metformin in comparison with other regimens of therapy for type 2 diabetes mellitus von Kolbin, A. S., Kurylev, A. A., Balykina, Yu. E., Proskurin, M. A.

Volltext

What is the role of antineoplastic drug safety in reimbursement decision making? von Kolbin, A. S., Kurylev, A. A.

Volltext

Overview of mathematical models of breast cancer von Yu. P. Yurkova, A. A. Kurylev, A. S. Kolbin

Volltext

Analysis of RWD/RWE recommendations and guidelines for 2021. International experience on the example of USA von Kurylev, A.

Volltext

Health-economic analysis of tocilizumab in patients with rheumatoid arthritis and systemic juvenile arthritis von Kolbin, A. S., Kurylev, A. A., Mishinova, S. A., Balykina, Yu. E., Proskurin, M. A.

Volltext

Analysis of effectiveness criteria in pharmacoeconomic studies of hypoglycemic drugs proposed for inclusion into the essential drug list in 2014-2016 in Russia von A. A. Mosikyan, A. A. Kurylev, A. S. Kolbin

Volltext

A mathematical model for predicting the development of bacterial resistance based on the relationship between the level of antimicrobial resistance and the volume of antibiotic con... von Arepyeva, M.A., Kolbin, A.S., Sidorenko, S.V., Lawson, R., Kurylev, A.A., Balykina, Yu E., Mukhina, N.V., Spiridonova, A.A.

Volltext

The social-economic burden of spinal muscular atrophy in Russia von Kolbin, A. S., Vlodavets, D. V., Kurylev, A. A., Balykina, Yu. Ye, Proskurin, M. A., Mishinova, S. A., Germanenko, O. Yu, Kolbina, N. Yu

Volltext

An update of pharmacoeconomic analysis of trastuzumab emtanzine in patients with HER2+ breast cancer and central nervous system metastases von A. S. Kolbin, A. A. Kurylev, Y. E. Balykina, M. A. Proskurin

Volltext

Pharmacoeconomic analysis of vemurafenib and dabrafenib use in patients with inoperable or metastatic melanoma with BRAF V600 mutation von A. S. Kolbin, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin

Volltext

Pharmacoeconomic analysis of trastuzumab emtanzine comparing to lapatinib + capecitabine in pa-tients with HER2+ breast cancer and central nervous system metastases von A. S. Kolbin, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, D. R. Naskhletashvili

Volltext

HEALTH ECONOMIC ASSESSMENT OF ANTIRHEUMATIC DRUGS IN PATIENTS WITH REUMATHOID ARTHRITIS PROGRESSED AFTER METOTREXATE von Kolbin, A. S., Kurylev, A. A., Proskurin, M. A., Balykina, Yu. E.

Volltext

Economic analysis of Lixisenatide in Diabetes Mellitus Type 2 von A. S. Kolbin, A. A. Mosikyan, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, W. Zhao

Volltext

Health Technologies Assessment for Orphan Diseases. Example of Social and Economic Burden of Spinal Muscular Atrophy von Kolbin, Aleksei S., Vlodavets, Dmitriy V., Kurylev, Aleksei A., Germanenko, Olga Yu, Kolbina, Natalia Yu

Volltext

Proposed changes ICER 2023 value assessment framework von Svechkareva, I. R., Kurylev, A. A.

Volltext

Real-world data studies in oncology: analysis of the Russian publications von Achikyan, V. F., Kurylev, A. A., Kolbin, A. S.

Volltext

DIARISK» — the first national prediabetes and diabetes mellitus type 2 risk calculator von Shestakova, Marina V., Kolbin, Alexey S., Galstyan, Gagik R., Arepeva, Maria A., Zaitseva, Ekaterina L., Mayorov, Alexander Y., Karpov, Oleg I., Proskurin, Maxim A., Kurylev, Aleksey A., Dedov, Ivan I.

Volltext